0001179110-11-014203.txt : 20111012 0001179110-11-014203.hdr.sgml : 20111012 20111012170653 ACCESSION NUMBER: 0001179110-11-014203 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111010 FILED AS OF DATE: 20111012 DATE AS OF CHANGE: 20111012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARTIN JOHN C CENTRAL INDEX KEY: 0001190578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 111138051 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: X1 ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgar.xml FORM 4 - X0304 4 2011-10-10 0 0000882095 GILEAD SCIENCES INC GILD 0001190578 MARTIN JOHN C GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 1 0 0 Chairman and CEO Common Stock 2011-10-10 4 M 0 92320 8.2188 A 2041535 D Common Stock 2011-10-10 4 S 0 92320 40.0040 D 1949215 D Non-Qualified Stock option (right to buy) 8.2188 2011-10-10 4 M 0 92320 0 D 2012-01-29 Common Stock 92320 184640 D Sale prices reported for the transaction reported here range from $40.00 to $40.05. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request. The options had a 5-year vesting schedule. 20% of the options vested on January 30, 2003, the first anniversary of the date of the grant. The balance vested 5% every three months thereafter until fully vested on January 30, 2007. The options expire on January 29, 2012. The exercise and sale transactions reported in this Form 4 made pursuant to a Rule 10b5-1 trading plan established by Dr. Martin on August 20, 2010. /s/ John C. Martin 2011-10-12